Association between experiencing side effects of artesunate/amodiaquine malaria chemoprevention (ASAQ-CP) in the first round of mass drug administration (MDA) with initiation of ASAQ-CP in the second round of the MDA, during the Ebola outbreak, Monrovia, Liberia, 2014 (Poisson regression).
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
https://figshare.com/articles/dataset/Association_between_experiencing_side_effects_of_artesunate_amodiaquine_malaria_chemoprevention_ASAQ-CP_in_the_first_round_of_mass_drug_administration_MDA_with_initiation_of_ASAQ-CP_in_the_second_round_of_the_MDA_during_the_Ebola_outbreak_Monrovia_Liberia/3865755数据链接链接失效反馈
官方服务：
资源简介：
Association between experiencing side effects of artesunate/amodiaquine malaria chemoprevention (ASAQ-CP) in the first round of mass drug administration (MDA) with initiation of ASAQ-CP in the second round of the MDA, during the Ebola outbreak, Monrovia, Liberia, 2014 (Poisson regression).
创建时间：
2016-09-28
